GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $242,000 | -26.4% | 3,559 | -53.2% | 0.01% | -12.5% |
| Q4 2020 | $329,000 | -80.1% | 7,601 | -63.5% | 0.01% | -27.3% |
| Q4 2019 | $1,656,000 | +6.4% | 20,818 | -29.7% | 0.01% | -31.2% |
| Q2 2019 | $1,557,000 | +21.5% | 29,600 | +22.3% | 0.02% | +45.5% |
| Q1 2019 | $1,281,000 | +263.9% | 24,200 | +153.5% | 0.01% | -84.1% |
| Q1 2017 | $352,000 | – | 9,546 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |